Champions Oncology
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
152.4N/A
Price/Sales ratio
1.721.53
Earnings per Share (EPS)
$0.05N/A

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.84-3.20-4.08-31.66804.44-46.29389.45184.95-12.33-9.03-20.44-46.29
Price/Sales ratio
7.182.991.822.353.802.843.432.061.221.311.182.84
Price/Book Value ratio
7.90140.6570.24-1.90K46.0017.1918.9711.1414.19-34.529.0217.19
Price/Cash Flow ratio
-6.61-5.18-9.89-38.8655.3031.47-83.8615.6016.64-10.7011.6731.47
Price/Free Cash Flow ratio
-6.53-4.94-7.79-19.40100.16133.47-28.4124.6460.76-9.4222.43133.47
Price/Earnings Growth ratio
-0.350.150.080.40-7.440.02-3.353.670.01-0.23-0.58-7.44
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
13.87%22.32%37.03%47.86%47.29%47.44%47.67%51.87%45.17%41.37%47.06%47.44%
Operating Profit Margin
-149.36%-92.25%-44.18%-6.68%0.99%-4.56%0.82%1.23%-8.25%-14.66%-5.67%-4.56%
Pretax Profit Margin
-146.82%-92.59%-44.54%-7.12%0.85%-5.74%0.99%1.18%-9.77%-14.57%-5.72%-5.74%
Net Profit Margin
-148.25%-93.41%-44.66%-7.43%0.47%-6.14%0.88%1.11%-9.90%-14.50%-5.80%-6.14%
Effective Tax Rate
-0.97%-0.88%-0.27%-4.36%44.58%-7.04%18.33%6.00%-1.29%0.43%-1.49%-7.04%
Return on Assets
-109.07%-180.82%-85.93%-18.63%1.13%-9.51%1.31%1.54%-15.54%-27.84%-8.62%-9.51%
Return On Equity
-163.04%-4389.07%-1721%6020%5.71%-37.13%4.87%6.02%-115.07%382.34%-36.34%-37.13%
Return on Capital Employed
-160.44%-2190.23%-1207.26%-227.18%8.33%-16.93%2.06%3.39%-35.37%-160.22%-19.83%-16.93%
Liquidity Ratios
Current Ratio
2.830.810.780.670.981.111.12N/AN/AN/A0.971.11
Quick Ratio
2.830.810.780.670.981.111.121.120.890.630.941.11
Cash ratio
2.460.480.440.110.400.690.410.510.460.120.550.40
Days of Sales Outstanding
43.6542.8253.8570.6359.0254.1962.1370.7054.2769.3254.7654.19
Days of Inventory outstanding
N/A0.000.000.000.000.00N/AN/A0.00N/AN/A0.00
Operating Cycle
43.6542.8253.8570.6359.0254.1962.1370.7054.2769.3213.5054.19
Days of Payables Outstanding
67.6179.6769.6674.5071.8267.8832.1944.2965.9272.0055.2067.88
Cash Conversion Cycle
-23.96-36.84-15.80-3.86-12.79-13.6829.9326.40-11.64-2.67-0.44-12.79
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.020.030.050.80N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A0.110.26-0.704.11N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.52N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.100.20-2.360.55N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A6.163.27-4.590.61N/A
Company Equity Multiplier
1.4924.2720.02-323.125.033.903.713.887.40-13.735.115.03
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.08-0.57-0.18-0.060.060.09-0.040.130.07-0.120.100.06
Free Cash Flow / Operating Cash Flow Ratio
1.011.041.262.000.550.232.950.630.271.130.520.23
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A6.163.27-4.590.61N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A6.163.27-4.594.68N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A